Article Index

HOPA Basic Science and Clinical Research Literature Award

This award recognizes an author who has written an important scientific article describing hematology/oncology basic science and/or translational research or clinical trials evaluating drug efficacy and/or safety.

2022    Lydia Benitez, PharmD, BCOP

Benitez LL, Perissinotti AJ, Rausch CR, Klaus J, Clark SM, Filtz M, Ratermann K, Treptow C, Griffin S, Olson M, Crain M, Kadia T, Pettit K, Burke PW, Bixby DL, Marini BL. Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia. Leuk Lymphoma. 2021 Apr 8:1-9. doi: 10.1080/10428194.2021.1907378. Epub ahead of print. PMID: 33830856.

2021    Victoria Nachar, PharmD, BCOP

Hoylman E, Brown A, Perissinotti A, et al. Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma. Leuk Lymphoma. 2020 Mar;61(3):691-698

2020    Daniel J. Crona, PharmD, PhD, CPP

Crona DJ, Skol AD, Leppänen V-M, Glubb DM, Etheridge AS, Hilliard E, Peña C, Peterson Y, Klauber-DeMore N, Alitalo KK, Innocenti F. Novel genetic determinants of survival in renal cell carcinoma patients treated with sorafenib: a clinical and translational experimental study. Cancer Res. 2019 Jan; 79(1):231-241. PMCID: PMC6541205.

2019    Judith A. Smith, BS PharmD BCOP CPHQ FCCP FISOPP

Cotton S, Brown RE, Nugent EK, Robazetti SC, Berens PD, Smith JA. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections. Obstetrics & Gynecology. 2018Apr;131(4):681–7.

2016    Meghana V. Trivedi, PharmD PhD BCOP

Do T, Medhekar R, Bhat R, Chen H, Niravath P, Trivedi MV. The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis. Breast Cancer Res Treat. 2015 Oct;153(3):591-7. Epub 2015 Sep 4.

2015    David J. Reeves, PharmD BCOP

Reeves DJ, Moore ES, Bascom D, Rensing B. Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors. Br J Clin Pharmacol. 2014 Sep;78(3):565-71. Doi: 10.1111/bcp.12384 PMID: 24646036

2014    Casey B. Williams, PharmD BCOP

Williams CB, Kambhampati S, Fiskus W, Wick J, Dutreix C, Ganguly S, Aljitawi O, Reyes R, Fleming A, Abhyankar S, Bhalla KN, McGuirk JP. Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia. Pharmacotherapy. 2013 Jun 24. doi: 10.1002/phar.1316.

2013    Wendelin Nelson, PharmD BCOP

Nelson WK, Formica RN, Cooper DL, Schwartz PE, Rutherford TJ. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers. J Oncol Pharm Pract 2012;18(3):323-332.

2012    Cindy O'Bryant, PharmD BCOP FCCP

O'Bryant CL, Haluska P, Rosen L, Ramanathan RK, Venugopal B, Leong S, Boinpally R, Franke A, Witt K, Evans J, Belani C, Gail Eckhardt S, Ramalingam S. An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function. Cancer Chemother Pharmacol. 2011 Sep 22

2011    Jacob K. Kettle, PharmD

Kettle JK, Grauer D, Folker TL, et al. Effectiveness of exogenous albumin administration for the prevention of ifosfamide-induced encephalopathy. Pharmacotherapy. 2010;30(8):812-817.

2010    LeAnne Kennedy, PharmD, BCOP

Kennedy LD, Case LD, Hurd DD, Cruz JM, Pomper GJ. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion. 2008;48:2285-91.